(Q53301555)

13 May 2018

title

Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. (English)

1 reference

13 May 2018

author name string

Bassett RM

series ordinal

1

1 reference

13 May 2018

Driebergen R

series ordinal

2

1 reference

13 May 2018

publication date

1 February 2005

1 reference

13 May 2018

Reproductive BioMedicine Online

published in

1 reference

13 May 2018

volume

10

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

169-177

1 reference

13 May 2018

Is luteinizing hormone needed for optimal ovulation induction?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Construction of Biologically Functional Bacterial Plasmids In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Structure-function relationship of recombinant follicle stimulating hormone (Puregon).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Improving insulin therapy: achievements and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

New developments in gonadotrophin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Genetic engineering of human FSH (Gonal-F).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

The natural history of HIV disease in haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Ovarian stimulation: from basic science to clinical application.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Prediction of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Preparation of growth hormone from pituitaries of man and monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Specifications for biotechnology-derived protein drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Physicochemical methods for predicting the biological potency of recombinant follicle stimulating hormone: an international collaborative study of isoelectric focusing and capillary zone electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Immunological and biological potencies of the different molecular species of gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960937-6

7 January 2021

10.1016/S1472-6483(10)60937-6

Identifiers

DOI

1 reference

13 May 2018

release_jgw6i3wqgvaljiql7zpoerizky

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jgw6i3wqgvaljiql7zpoerizky

24 November 2022

mapped directly with Wikidata item

1 reference

13 May 2018